nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—CES1—Capecitabine—esophageal cancer	0.399	0.751	CbGbCtD
Clopidogrel—ABCB1—esophageal cancer	0.236	1	CbGaD
Clopidogrel—CYP2C9—Capecitabine—esophageal cancer	0.0405	0.0762	CbGbCtD
Clopidogrel—CYP2B6—Cisplatin—esophageal cancer	0.0386	0.0727	CbGbCtD
Clopidogrel—CYP2C9—Cisplatin—esophageal cancer	0.0204	0.0384	CbGbCtD
Clopidogrel—ABCB1—Cisplatin—esophageal cancer	0.0198	0.0373	CbGbCtD
Clopidogrel—ABCB1—Methotrexate—esophageal cancer	0.0129	0.0242	CbGbCtD
Clopidogrel—CES1—larynx—esophageal cancer	0.00512	0.371	CbGeAlD
Clopidogrel—P2RY12—epithelium—esophageal cancer	0.00176	0.128	CbGeAlD
Clopidogrel—CES1—neck—esophageal cancer	0.00136	0.0985	CbGeAlD
Clopidogrel—CES1—digestive system—esophageal cancer	0.000703	0.051	CbGeAlD
Clopidogrel—Body temperature increased—Carboplatin—esophageal cancer	0.000672	0.00605	CcSEcCtD
Clopidogrel—Fluid retention—Cisplatin—esophageal cancer	0.000664	0.00598	CcSEcCtD
Clopidogrel—Coagulopathy—Capecitabine—esophageal cancer	0.000662	0.00596	CcSEcCtD
Clopidogrel—Skin ulcer—Capecitabine—esophageal cancer	0.000662	0.00596	CcSEcCtD
Clopidogrel—Contusion—Capecitabine—esophageal cancer	0.00059	0.00532	CcSEcCtD
Clopidogrel—CES1—lung—esophageal cancer	0.000587	0.0426	CbGeAlD
Clopidogrel—Deafness—Cisplatin—esophageal cancer	0.000567	0.00511	CcSEcCtD
Clopidogrel—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.000567	0.0051	CcSEcCtD
Clopidogrel—Renal failure acute—Cisplatin—esophageal cancer	0.00055	0.00495	CcSEcCtD
Clopidogrel—Ulcer—Capecitabine—esophageal cancer	0.000545	0.00491	CcSEcCtD
Clopidogrel—Interstitial lung disease—Methotrexate—esophageal cancer	0.000542	0.00488	CcSEcCtD
Clopidogrel—Cataract—Capecitabine—esophageal cancer	0.000541	0.00488	CcSEcCtD
Clopidogrel—Hearing impaired—Capecitabine—esophageal cancer	0.000541	0.00488	CcSEcCtD
Clopidogrel—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000524	0.00472	CcSEcCtD
Clopidogrel—Pulmonary embolism—Capecitabine—esophageal cancer	0.000515	0.00464	CcSEcCtD
Clopidogrel—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000507	0.00457	CcSEcCtD
Clopidogrel—Influenza like illness—Capecitabine—esophageal cancer	0.0005	0.00451	CcSEcCtD
Clopidogrel—Colitis—Capecitabine—esophageal cancer	0.000495	0.00446	CcSEcCtD
Clopidogrel—Skin ulcer—Methotrexate—esophageal cancer	0.000493	0.00444	CcSEcCtD
Clopidogrel—Fluid retention—Capecitabine—esophageal cancer	0.000489	0.00441	CcSEcCtD
Clopidogrel—Blood creatinine increased—Cisplatin—esophageal cancer	0.000475	0.00428	CcSEcCtD
Clopidogrel—Oesophagitis—Capecitabine—esophageal cancer	0.000471	0.00424	CcSEcCtD
Clopidogrel—Ecchymosis—Capecitabine—esophageal cancer	0.000466	0.0042	CcSEcCtD
Clopidogrel—Pancreatitis—Cisplatin—esophageal cancer	0.00043	0.00387	CcSEcCtD
Clopidogrel—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000428	0.00385	CcSEcCtD
Clopidogrel—Bone disorder—Methotrexate—esophageal cancer	0.000425	0.00383	CcSEcCtD
Clopidogrel—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.000422	0.0038	CcSEcCtD
Clopidogrel—Deafness—Capecitabine—esophageal cancer	0.000418	0.00377	CcSEcCtD
Clopidogrel—Vascular purpura—Capecitabine—esophageal cancer	0.000418	0.00377	CcSEcCtD
Clopidogrel—Pancytopenia—Cisplatin—esophageal cancer	0.000416	0.00375	CcSEcCtD
Clopidogrel—Hyperuricaemia—Methotrexate—esophageal cancer	0.000413	0.00372	CcSEcCtD
Clopidogrel—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000405	0.00365	CcSEcCtD
Clopidogrel—Ulcer—Methotrexate—esophageal cancer	0.000405	0.00365	CcSEcCtD
Clopidogrel—Renal failure acute—Capecitabine—esophageal cancer	0.000405	0.00365	CcSEcCtD
Clopidogrel—CES1—lymph node—esophageal cancer	0.000402	0.0291	CbGeAlD
Clopidogrel—CYP2B6—bronchus—esophageal cancer	0.000399	0.0289	CbGeAlD
Clopidogrel—CYP2C19—digestive system—esophageal cancer	0.000394	0.0285	CbGeAlD
Clopidogrel—Renal impairment—Capecitabine—esophageal cancer	0.000393	0.00354	CcSEcCtD
Clopidogrel—Vasculitis—Methotrexate—esophageal cancer	0.000393	0.00354	CcSEcCtD
Clopidogrel—Dermatitis bullous—Capecitabine—esophageal cancer	0.000391	0.00352	CcSEcCtD
Clopidogrel—Blood uric acid increased—Methotrexate—esophageal cancer	0.000391	0.00352	CcSEcCtD
Clopidogrel—Purpura—Capecitabine—esophageal cancer	0.000388	0.0035	CcSEcCtD
Clopidogrel—Arthritis—Capecitabine—esophageal cancer	0.000385	0.00347	CcSEcCtD
Clopidogrel—Renal failure—Cisplatin—esophageal cancer	0.000384	0.00346	CcSEcCtD
Clopidogrel—Pulmonary embolism—Methotrexate—esophageal cancer	0.000384	0.00346	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000383	0.00345	CcSEcCtD
Clopidogrel—Cardiac failure—Capecitabine—esophageal cancer	0.000383	0.00345	CcSEcCtD
Clopidogrel—Stomatitis—Cisplatin—esophageal cancer	0.000381	0.00343	CcSEcCtD
Clopidogrel—Conjunctivitis—Cisplatin—esophageal cancer	0.00038	0.00342	CcSEcCtD
Clopidogrel—Cystitis noninfective—Methotrexate—esophageal cancer	0.000375	0.00337	CcSEcCtD
Clopidogrel—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000374	0.00337	CcSEcCtD
Clopidogrel—Osteoarthritis—Capecitabine—esophageal cancer	0.000374	0.00337	CcSEcCtD
Clopidogrel—Cystitis—Methotrexate—esophageal cancer	0.00037	0.00334	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00037	0.00333	CcSEcCtD
Clopidogrel—Aplastic anaemia—Methotrexate—esophageal cancer	0.00036	0.00324	CcSEcCtD
Clopidogrel—Blood creatinine increased—Capecitabine—esophageal cancer	0.00035	0.00316	CcSEcCtD
Clopidogrel—Bladder pain—Methotrexate—esophageal cancer	0.000347	0.00312	CcSEcCtD
Clopidogrel—Ecchymosis—Methotrexate—esophageal cancer	0.000347	0.00312	CcSEcCtD
Clopidogrel—Urinary tract disorder—Cisplatin—esophageal cancer	0.000347	0.00312	CcSEcCtD
Clopidogrel—Liver function test abnormal—Capecitabine—esophageal cancer	0.000345	0.00311	CcSEcCtD
Clopidogrel—Urethral disorder—Cisplatin—esophageal cancer	0.000344	0.0031	CcSEcCtD
Clopidogrel—Abdominal pain upper—Capecitabine—esophageal cancer	0.000342	0.00308	CcSEcCtD
Clopidogrel—Visual impairment—Cisplatin—esophageal cancer	0.000338	0.00305	CcSEcCtD
Clopidogrel—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000337	0.00303	CcSEcCtD
Clopidogrel—Gastritis—Capecitabine—esophageal cancer	0.000331	0.00298	CcSEcCtD
Clopidogrel—Eye disorder—Cisplatin—esophageal cancer	0.000328	0.00295	CcSEcCtD
Clopidogrel—Tinnitus—Cisplatin—esophageal cancer	0.000327	0.00295	CcSEcCtD
Clopidogrel—Abdominal distension—Capecitabine—esophageal cancer	0.000325	0.00293	CcSEcCtD
Clopidogrel—Asthma—Capecitabine—esophageal cancer	0.000323	0.00291	CcSEcCtD
Clopidogrel—CYP1A2—digestive system—esophageal cancer	0.000321	0.0233	CbGeAlD
Clopidogrel—Bronchospasm—Capecitabine—esophageal cancer	0.000318	0.00286	CcSEcCtD
Clopidogrel—Immune system disorder—Cisplatin—esophageal cancer	0.000317	0.00286	CcSEcCtD
Clopidogrel—Mediastinal disorder—Cisplatin—esophageal cancer	0.000316	0.00285	CcSEcCtD
Clopidogrel—Angina pectoris—Capecitabine—esophageal cancer	0.000315	0.00284	CcSEcCtD
Clopidogrel—Bronchitis—Capecitabine—esophageal cancer	0.000311	0.0028	CcSEcCtD
Clopidogrel—CYP3A5—digestive system—esophageal cancer	0.00031	0.0225	CbGeAlD
Clopidogrel—CYP2B6—digestive system—esophageal cancer	0.000308	0.0223	CbGeAlD
Clopidogrel—Pancytopenia—Capecitabine—esophageal cancer	0.000307	0.00277	CcSEcCtD
Clopidogrel—Malnutrition—Cisplatin—esophageal cancer	0.000306	0.00275	CcSEcCtD
Clopidogrel—CYP2C9—digestive system—esophageal cancer	0.000305	0.0221	CbGeAlD
Clopidogrel—Neutropenia—Capecitabine—esophageal cancer	0.000302	0.00272	CcSEcCtD
Clopidogrel—Renal failure acute—Methotrexate—esophageal cancer	0.000302	0.00272	CcSEcCtD
Clopidogrel—Flatulence—Cisplatin—esophageal cancer	0.000301	0.00271	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.0003	0.00271	CcSEcCtD
Clopidogrel—Muscle spasms—Cisplatin—esophageal cancer	0.000294	0.00265	CcSEcCtD
Clopidogrel—Pneumonia—Capecitabine—esophageal cancer	0.00029	0.00261	CcSEcCtD
Clopidogrel—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000288	0.00259	CcSEcCtD
Clopidogrel—Depression—Capecitabine—esophageal cancer	0.000287	0.00259	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000286	0.00257	CcSEcCtD
Clopidogrel—Renal failure—Capecitabine—esophageal cancer	0.000283	0.00255	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000283	0.00254	CcSEcCtD
Clopidogrel—Anaemia—Cisplatin—esophageal cancer	0.000282	0.00254	CcSEcCtD
Clopidogrel—Stomatitis—Capecitabine—esophageal cancer	0.000281	0.00253	CcSEcCtD
Clopidogrel—Urinary tract infection—Capecitabine—esophageal cancer	0.00028	0.00252	CcSEcCtD
Clopidogrel—Conjunctivitis—Capecitabine—esophageal cancer	0.00028	0.00252	CcSEcCtD
Clopidogrel—Osteoarthritis—Methotrexate—esophageal cancer	0.000278	0.00251	CcSEcCtD
Clopidogrel—Haematuria—Capecitabine—esophageal cancer	0.000275	0.00248	CcSEcCtD
Clopidogrel—Leukopenia—Cisplatin—esophageal cancer	0.000273	0.00246	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000273	0.00246	CcSEcCtD
Clopidogrel—Epistaxis—Capecitabine—esophageal cancer	0.000272	0.00245	CcSEcCtD
Clopidogrel—Agranulocytosis—Capecitabine—esophageal cancer	0.000269	0.00242	CcSEcCtD
Clopidogrel—CYP1A2—lung—esophageal cancer	0.000268	0.0195	CbGeAlD
Clopidogrel—Myalgia—Cisplatin—esophageal cancer	0.00026	0.00234	CcSEcCtD
Clopidogrel—Haemoglobin—Capecitabine—esophageal cancer	0.00026	0.00234	CcSEcCtD
Clopidogrel—Rhinitis—Capecitabine—esophageal cancer	0.000259	0.00234	CcSEcCtD
Clopidogrel—Anxiety—Cisplatin—esophageal cancer	0.000259	0.00234	CcSEcCtD
Clopidogrel—CYP3A5—lung—esophageal cancer	0.000259	0.0188	CbGeAlD
Clopidogrel—Hepatitis—Capecitabine—esophageal cancer	0.000259	0.00233	CcSEcCtD
Clopidogrel—Haemorrhage—Capecitabine—esophageal cancer	0.000259	0.00233	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000258	0.00233	CcSEcCtD
Clopidogrel—Hypoaesthesia—Capecitabine—esophageal cancer	0.000257	0.00232	CcSEcCtD
Clopidogrel—CYP2B6—lung—esophageal cancer	0.000257	0.0187	CbGeAlD
Clopidogrel—Liver function test abnormal—Methotrexate—esophageal cancer	0.000257	0.00232	CcSEcCtD
Clopidogrel—Urinary tract disorder—Capecitabine—esophageal cancer	0.000256	0.0023	CcSEcCtD
Clopidogrel—Oedema peripheral—Capecitabine—esophageal cancer	0.000255	0.0023	CcSEcCtD
Clopidogrel—Urethral disorder—Capecitabine—esophageal cancer	0.000254	0.00228	CcSEcCtD
Clopidogrel—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000251	0.00226	CcSEcCtD
Clopidogrel—Oedema—Cisplatin—esophageal cancer	0.000249	0.00225	CcSEcCtD
Clopidogrel—Anaphylactic shock—Cisplatin—esophageal cancer	0.000249	0.00225	CcSEcCtD
Clopidogrel—Visual impairment—Capecitabine—esophageal cancer	0.000249	0.00225	CcSEcCtD
Clopidogrel—Infection—Cisplatin—esophageal cancer	0.000248	0.00223	CcSEcCtD
Clopidogrel—Erythema multiforme—Capecitabine—esophageal cancer	0.000245	0.0022	CcSEcCtD
Clopidogrel—Nervous system disorder—Cisplatin—esophageal cancer	0.000245	0.0022	CcSEcCtD
Clopidogrel—Skin disorder—Cisplatin—esophageal cancer	0.000242	0.00218	CcSEcCtD
Clopidogrel—Eye disorder—Capecitabine—esophageal cancer	0.000242	0.00218	CcSEcCtD
Clopidogrel—Tinnitus—Capecitabine—esophageal cancer	0.000241	0.00217	CcSEcCtD
Clopidogrel—Asthma—Methotrexate—esophageal cancer	0.000241	0.00217	CcSEcCtD
Clopidogrel—Eosinophilia—Methotrexate—esophageal cancer	0.000238	0.00215	CcSEcCtD
Clopidogrel—Pancreatitis—Methotrexate—esophageal cancer	0.000236	0.00213	CcSEcCtD
Clopidogrel—Angiopathy—Capecitabine—esophageal cancer	0.000235	0.00211	CcSEcCtD
Clopidogrel—Immune system disorder—Capecitabine—esophageal cancer	0.000234	0.00211	CcSEcCtD
Clopidogrel—Mediastinal disorder—Capecitabine—esophageal cancer	0.000233	0.0021	CcSEcCtD
Clopidogrel—Hypotension—Cisplatin—esophageal cancer	0.000233	0.0021	CcSEcCtD
Clopidogrel—CYP3A4—digestive system—esophageal cancer	0.000233	0.0169	CbGeAlD
Clopidogrel—Pancytopenia—Methotrexate—esophageal cancer	0.000229	0.00206	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000227	0.00205	CcSEcCtD
Clopidogrel—Mental disorder—Capecitabine—esophageal cancer	0.000227	0.00204	CcSEcCtD
Clopidogrel—Malnutrition—Capecitabine—esophageal cancer	0.000225	0.00203	CcSEcCtD
Clopidogrel—Neutropenia—Methotrexate—esophageal cancer	0.000225	0.00203	CcSEcCtD
Clopidogrel—Paraesthesia—Cisplatin—esophageal cancer	0.000224	0.00202	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000224	0.00201	CcSEcCtD
Clopidogrel—Dyspnoea—Cisplatin—esophageal cancer	0.000222	0.002	CcSEcCtD
Clopidogrel—Flatulence—Capecitabine—esophageal cancer	0.000222	0.002	CcSEcCtD
Clopidogrel—Back pain—Capecitabine—esophageal cancer	0.000218	0.00196	CcSEcCtD
Clopidogrel—Muscle spasms—Capecitabine—esophageal cancer	0.000217	0.00195	CcSEcCtD
Clopidogrel—ABCB1—epithelium—esophageal cancer	0.000217	0.0157	CbGeAlD
Clopidogrel—Pneumonia—Methotrexate—esophageal cancer	0.000216	0.00194	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000215	0.00194	CcSEcCtD
Clopidogrel—Depression—Methotrexate—esophageal cancer	0.000214	0.00193	CcSEcCtD
Clopidogrel—Pain—Cisplatin—esophageal cancer	0.000213	0.00192	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000213	0.00192	CcSEcCtD
Clopidogrel—Renal failure—Methotrexate—esophageal cancer	0.000211	0.0019	CcSEcCtD
Clopidogrel—Stomatitis—Methotrexate—esophageal cancer	0.000209	0.00188	CcSEcCtD
Clopidogrel—Conjunctivitis—Methotrexate—esophageal cancer	0.000209	0.00188	CcSEcCtD
Clopidogrel—Anaemia—Capecitabine—esophageal cancer	0.000208	0.00188	CcSEcCtD
Clopidogrel—Feeling abnormal—Cisplatin—esophageal cancer	0.000205	0.00185	CcSEcCtD
Clopidogrel—Haematuria—Methotrexate—esophageal cancer	0.000205	0.00184	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000203	0.00183	CcSEcCtD
Clopidogrel—Epistaxis—Methotrexate—esophageal cancer	0.000202	0.00182	CcSEcCtD
Clopidogrel—Vertigo—Capecitabine—esophageal cancer	0.000202	0.00182	CcSEcCtD
Clopidogrel—Syncope—Capecitabine—esophageal cancer	0.000202	0.00182	CcSEcCtD
Clopidogrel—Leukopenia—Capecitabine—esophageal cancer	0.000202	0.00182	CcSEcCtD
Clopidogrel—Agranulocytosis—Methotrexate—esophageal cancer	0.0002	0.0018	CcSEcCtD
Clopidogrel—Palpitations—Capecitabine—esophageal cancer	0.000199	0.00179	CcSEcCtD
Clopidogrel—Loss of consciousness—Capecitabine—esophageal cancer	0.000198	0.00178	CcSEcCtD
Clopidogrel—Body temperature increased—Cisplatin—esophageal cancer	0.000197	0.00178	CcSEcCtD
Clopidogrel—Cough—Capecitabine—esophageal cancer	0.000197	0.00177	CcSEcCtD
Clopidogrel—Hypertension—Capecitabine—esophageal cancer	0.000194	0.00175	CcSEcCtD
Clopidogrel—Haemoglobin—Methotrexate—esophageal cancer	0.000194	0.00174	CcSEcCtD
Clopidogrel—Hepatitis—Methotrexate—esophageal cancer	0.000193	0.00174	CcSEcCtD
Clopidogrel—Haemorrhage—Methotrexate—esophageal cancer	0.000193	0.00174	CcSEcCtD
Clopidogrel—Chest pain—Capecitabine—esophageal cancer	0.000192	0.00173	CcSEcCtD
Clopidogrel—Arthralgia—Capecitabine—esophageal cancer	0.000192	0.00173	CcSEcCtD
Clopidogrel—Myalgia—Capecitabine—esophageal cancer	0.000192	0.00173	CcSEcCtD
Clopidogrel—ABCB1—trachea—esophageal cancer	0.000191	0.0139	CbGeAlD
Clopidogrel—Anxiety—Capecitabine—esophageal cancer	0.000191	0.00172	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00019	0.00172	CcSEcCtD
Clopidogrel—Urinary tract disorder—Methotrexate—esophageal cancer	0.00019	0.00171	CcSEcCtD
Clopidogrel—Urethral disorder—Methotrexate—esophageal cancer	0.000189	0.0017	CcSEcCtD
Clopidogrel—Visual impairment—Methotrexate—esophageal cancer	0.000186	0.00167	CcSEcCtD
Clopidogrel—Confusional state—Capecitabine—esophageal cancer	0.000185	0.00167	CcSEcCtD
Clopidogrel—Oedema—Capecitabine—esophageal cancer	0.000184	0.00166	CcSEcCtD
Clopidogrel—Hypersensitivity—Cisplatin—esophageal cancer	0.000184	0.00165	CcSEcCtD
Clopidogrel—Infection—Capecitabine—esophageal cancer	0.000183	0.00165	CcSEcCtD
Clopidogrel—Erythema multiforme—Methotrexate—esophageal cancer	0.000182	0.00164	CcSEcCtD
Clopidogrel—Shock—Capecitabine—esophageal cancer	0.000181	0.00163	CcSEcCtD
Clopidogrel—Nervous system disorder—Capecitabine—esophageal cancer	0.00018	0.00162	CcSEcCtD
Clopidogrel—Eye disorder—Methotrexate—esophageal cancer	0.00018	0.00162	CcSEcCtD
Clopidogrel—Tinnitus—Methotrexate—esophageal cancer	0.00018	0.00162	CcSEcCtD
Clopidogrel—Asthenia—Cisplatin—esophageal cancer	0.000179	0.00161	CcSEcCtD
Clopidogrel—Skin disorder—Capecitabine—esophageal cancer	0.000179	0.00161	CcSEcCtD
Clopidogrel—Angiopathy—Methotrexate—esophageal cancer	0.000175	0.00157	CcSEcCtD
Clopidogrel—Immune system disorder—Methotrexate—esophageal cancer	0.000174	0.00157	CcSEcCtD
Clopidogrel—Mediastinal disorder—Methotrexate—esophageal cancer	0.000174	0.00156	CcSEcCtD
Clopidogrel—Hypotension—Capecitabine—esophageal cancer	0.000172	0.00155	CcSEcCtD
Clopidogrel—Diarrhoea—Cisplatin—esophageal cancer	0.000171	0.00154	CcSEcCtD
Clopidogrel—Mental disorder—Methotrexate—esophageal cancer	0.000169	0.00152	CcSEcCtD
Clopidogrel—Malnutrition—Methotrexate—esophageal cancer	0.000168	0.00151	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000167	0.00151	CcSEcCtD
Clopidogrel—Insomnia—Capecitabine—esophageal cancer	0.000166	0.0015	CcSEcCtD
Clopidogrel—Paraesthesia—Capecitabine—esophageal cancer	0.000165	0.00149	CcSEcCtD
Clopidogrel—ABCB1—digestive system—esophageal cancer	0.000165	0.0119	CbGeAlD
Clopidogrel—Dyspnoea—Capecitabine—esophageal cancer	0.000164	0.00148	CcSEcCtD
Clopidogrel—Back pain—Methotrexate—esophageal cancer	0.000162	0.00146	CcSEcCtD
Clopidogrel—Dyspepsia—Capecitabine—esophageal cancer	0.000162	0.00146	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000159	0.00143	CcSEcCtD
Clopidogrel—Vomiting—Cisplatin—esophageal cancer	0.000159	0.00143	CcSEcCtD
Clopidogrel—Fatigue—Capecitabine—esophageal cancer	0.000158	0.00143	CcSEcCtD
Clopidogrel—Rash—Cisplatin—esophageal cancer	0.000157	0.00142	CcSEcCtD
Clopidogrel—Constipation—Capecitabine—esophageal cancer	0.000157	0.00142	CcSEcCtD
Clopidogrel—Pain—Capecitabine—esophageal cancer	0.000157	0.00142	CcSEcCtD
Clopidogrel—Dermatitis—Cisplatin—esophageal cancer	0.000157	0.00142	CcSEcCtD
Clopidogrel—Anaemia—Methotrexate—esophageal cancer	0.000155	0.0014	CcSEcCtD
Clopidogrel—Feeling abnormal—Capecitabine—esophageal cancer	0.000151	0.00136	CcSEcCtD
Clopidogrel—Vertigo—Methotrexate—esophageal cancer	0.000151	0.00136	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00015	0.00135	CcSEcCtD
Clopidogrel—Leukopenia—Methotrexate—esophageal cancer	0.00015	0.00135	CcSEcCtD
Clopidogrel—Nausea—Cisplatin—esophageal cancer	0.000148	0.00133	CcSEcCtD
Clopidogrel—Cough—Methotrexate—esophageal cancer	0.000146	0.00132	CcSEcCtD
Clopidogrel—Urticaria—Capecitabine—esophageal cancer	0.000146	0.00132	CcSEcCtD
Clopidogrel—Abdominal pain—Capecitabine—esophageal cancer	0.000145	0.00131	CcSEcCtD
Clopidogrel—Body temperature increased—Capecitabine—esophageal cancer	0.000145	0.00131	CcSEcCtD
Clopidogrel—Myalgia—Methotrexate—esophageal cancer	0.000143	0.00129	CcSEcCtD
Clopidogrel—Chest pain—Methotrexate—esophageal cancer	0.000143	0.00129	CcSEcCtD
Clopidogrel—Arthralgia—Methotrexate—esophageal cancer	0.000143	0.00129	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000142	0.00128	CcSEcCtD
Clopidogrel—Confusional state—Methotrexate—esophageal cancer	0.000138	0.00124	CcSEcCtD
Clopidogrel—ABCB1—lung—esophageal cancer	0.000138	0.00997	CbGeAlD
Clopidogrel—Anaphylactic shock—Methotrexate—esophageal cancer	0.000137	0.00123	CcSEcCtD
Clopidogrel—Infection—Methotrexate—esophageal cancer	0.000136	0.00122	CcSEcCtD
Clopidogrel—Hypersensitivity—Capecitabine—esophageal cancer	0.000135	0.00122	CcSEcCtD
Clopidogrel—Nervous system disorder—Methotrexate—esophageal cancer	0.000134	0.00121	CcSEcCtD
Clopidogrel—Skin disorder—Methotrexate—esophageal cancer	0.000133	0.0012	CcSEcCtD
Clopidogrel—Asthenia—Capecitabine—esophageal cancer	0.000132	0.00119	CcSEcCtD
Clopidogrel—Pruritus—Capecitabine—esophageal cancer	0.00013	0.00117	CcSEcCtD
Clopidogrel—Hypotension—Methotrexate—esophageal cancer	0.000128	0.00115	CcSEcCtD
Clopidogrel—Diarrhoea—Capecitabine—esophageal cancer	0.000126	0.00113	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000125	0.00112	CcSEcCtD
Clopidogrel—Insomnia—Methotrexate—esophageal cancer	0.000124	0.00111	CcSEcCtD
Clopidogrel—Paraesthesia—Methotrexate—esophageal cancer	0.000123	0.00111	CcSEcCtD
Clopidogrel—Dyspnoea—Methotrexate—esophageal cancer	0.000122	0.0011	CcSEcCtD
Clopidogrel—Dizziness—Capecitabine—esophageal cancer	0.000122	0.00109	CcSEcCtD
Clopidogrel—Dyspepsia—Methotrexate—esophageal cancer	0.00012	0.00109	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000118	0.00106	CcSEcCtD
Clopidogrel—Fatigue—Methotrexate—esophageal cancer	0.000118	0.00106	CcSEcCtD
Clopidogrel—Pain—Methotrexate—esophageal cancer	0.000117	0.00105	CcSEcCtD
Clopidogrel—Vomiting—Capecitabine—esophageal cancer	0.000117	0.00105	CcSEcCtD
Clopidogrel—Rash—Capecitabine—esophageal cancer	0.000116	0.00104	CcSEcCtD
Clopidogrel—Dermatitis—Capecitabine—esophageal cancer	0.000116	0.00104	CcSEcCtD
Clopidogrel—Headache—Capecitabine—esophageal cancer	0.000115	0.00104	CcSEcCtD
Clopidogrel—Feeling abnormal—Methotrexate—esophageal cancer	0.000113	0.00102	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000112	0.00101	CcSEcCtD
Clopidogrel—Nausea—Capecitabine—esophageal cancer	0.000109	0.000984	CcSEcCtD
Clopidogrel—Urticaria—Methotrexate—esophageal cancer	0.000109	0.000979	CcSEcCtD
Clopidogrel—Body temperature increased—Methotrexate—esophageal cancer	0.000108	0.000974	CcSEcCtD
Clopidogrel—Abdominal pain—Methotrexate—esophageal cancer	0.000108	0.000974	CcSEcCtD
Clopidogrel—Hypersensitivity—Methotrexate—esophageal cancer	0.000101	0.000908	CcSEcCtD
Clopidogrel—Asthenia—Methotrexate—esophageal cancer	9.82e-05	0.000884	CcSEcCtD
Clopidogrel—Pruritus—Methotrexate—esophageal cancer	9.68e-05	0.000872	CcSEcCtD
Clopidogrel—ABCB1—lymph node—esophageal cancer	9.41e-05	0.00682	CbGeAlD
Clopidogrel—Diarrhoea—Methotrexate—esophageal cancer	9.36e-05	0.000843	CcSEcCtD
Clopidogrel—Dizziness—Methotrexate—esophageal cancer	9.05e-05	0.000815	CcSEcCtD
Clopidogrel—Vomiting—Methotrexate—esophageal cancer	8.7e-05	0.000784	CcSEcCtD
Clopidogrel—Rash—Methotrexate—esophageal cancer	8.63e-05	0.000777	CcSEcCtD
Clopidogrel—Dermatitis—Methotrexate—esophageal cancer	8.62e-05	0.000776	CcSEcCtD
Clopidogrel—Headache—Methotrexate—esophageal cancer	8.57e-05	0.000772	CcSEcCtD
Clopidogrel—Nausea—Methotrexate—esophageal cancer	8.13e-05	0.000732	CcSEcCtD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	2.06e-05	0.000192	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CREBBP—esophageal cancer	2.06e-05	0.000192	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.05e-05	0.000191	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ALDOB—esophageal cancer	2.05e-05	0.000191	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.04e-05	0.00019	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—EGFR—esophageal cancer	2.03e-05	0.000188	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ALDOB—esophageal cancer	2e-05	0.000186	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—TYMP—esophageal cancer	2e-05	0.000186	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GAPDH—esophageal cancer	1.97e-05	0.000184	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.96e-05	0.000183	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CRABP1—esophageal cancer	1.96e-05	0.000182	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—SLC10A2—esophageal cancer	1.95e-05	0.000182	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CA1—esophageal cancer	1.95e-05	0.000182	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYP26A1—esophageal cancer	1.95e-05	0.000181	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.94e-05	0.000181	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ADH7—esophageal cancer	1.94e-05	0.000181	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—PIK3CA—esophageal cancer	1.94e-05	0.00018	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GAPDH—esophageal cancer	1.93e-05	0.000179	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.92e-05	0.000179	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CRABP1—esophageal cancer	1.91e-05	0.000178	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ALOX15—esophageal cancer	1.9e-05	0.000177	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ADH1B—esophageal cancer	1.87e-05	0.000174	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GNG7—esophageal cancer	1.86e-05	0.000173	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—NOS3—esophageal cancer	1.85e-05	0.000172	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ADH1B—esophageal cancer	1.83e-05	0.00017	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GNG7—esophageal cancer	1.82e-05	0.000169	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—TPI1—esophageal cancer	1.81e-05	0.000168	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GSTO1—esophageal cancer	1.81e-05	0.000168	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CA2—esophageal cancer	1.79e-05	0.000166	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—TYMP—esophageal cancer	1.79e-05	0.000166	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.79e-05	0.000166	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.77e-05	0.000165	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.77e-05	0.000165	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—PIK3CA—esophageal cancer	1.76e-05	0.000164	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.75e-05	0.000162	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—TYMP—esophageal cancer	1.74e-05	0.000162	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ALDH2—esophageal cancer	1.74e-05	0.000162	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP26A1—esophageal cancer	1.74e-05	0.000162	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.74e-05	0.000161	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—ERBB2—esophageal cancer	1.73e-05	0.000161	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.71e-05	0.000159	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.71e-05	0.000159	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ALDH2—esophageal cancer	1.7e-05	0.000159	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.7e-05	0.000158	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ALOX15—esophageal cancer	1.69e-05	0.000158	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.67e-05	0.000156	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.67e-05	0.000155	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PLCE1—esophageal cancer	1.66e-05	0.000155	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ADH7—esophageal cancer	1.66e-05	0.000155	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—GSTT1—esophageal cancer	1.66e-05	0.000154	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.66e-05	0.000154	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ALOX15—esophageal cancer	1.65e-05	0.000154	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.64e-05	0.000153	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYP2A6—esophageal cancer	1.64e-05	0.000152	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—TYMP—esophageal cancer	1.63e-05	0.000152	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—GSTT1—esophageal cancer	1.62e-05	0.000151	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.62e-05	0.00015	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—TPI1—esophageal cancer	1.62e-05	0.00015	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYP2A6—esophageal cancer	1.6e-05	0.000149	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.59e-05	0.000147	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—TPI1—esophageal cancer	1.58e-05	0.000147	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSTO1—esophageal cancer	1.58e-05	0.000147	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GNG7—esophageal cancer	1.58e-05	0.000147	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PTGS1—esophageal cancer	1.55e-05	0.000145	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ENO1—esophageal cancer	1.55e-05	0.000145	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.55e-05	0.000144	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.55e-05	0.000144	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PSME1—esophageal cancer	1.53e-05	0.000142	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PSME2—esophageal cancer	1.53e-05	0.000142	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CCND1—esophageal cancer	1.53e-05	0.000142	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PTGS1—esophageal cancer	1.52e-05	0.000141	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ENO1—esophageal cancer	1.52e-05	0.000141	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ALDOB—esophageal cancer	1.51e-05	0.000141	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.51e-05	0.00014	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CA1—esophageal cancer	1.51e-05	0.00014	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PSME2—esophageal cancer	1.5e-05	0.000139	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PSME1—esophageal cancer	1.5e-05	0.000139	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.49e-05	0.000139	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.48e-05	0.000137	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.48e-05	0.000137	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CDKN1A—esophageal cancer	1.48e-05	0.000137	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—TPI1—esophageal cancer	1.47e-05	0.000137	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.47e-05	0.000137	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ADH1B—esophageal cancer	1.46e-05	0.000136	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GAPDH—esophageal cancer	1.46e-05	0.000135	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.45e-05	0.000135	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CRABP1—esophageal cancer	1.44e-05	0.000134	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.41e-05	0.000131	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GNG7—esophageal cancer	1.41e-05	0.000131	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.41e-05	0.000131	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—EP300—esophageal cancer	1.4e-05	0.000131	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.4e-05	0.000131	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—TYMP—esophageal cancer	1.39e-05	0.00013	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.39e-05	0.000129	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.38e-05	0.000129	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CA2—esophageal cancer	1.38e-05	0.000128	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GNG7—esophageal cancer	1.37e-05	0.000128	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.36e-05	0.000126	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.35e-05	0.000126	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.35e-05	0.000125	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYP1B1—esophageal cancer	1.32e-05	0.000123	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.32e-05	0.000123	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.32e-05	0.000123	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ENO1—esophageal cancer	1.32e-05	0.000122	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.32e-05	0.000122	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PSME1—esophageal cancer	1.3e-05	0.000121	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PSME2—esophageal cancer	1.3e-05	0.000121	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYP1B1—esophageal cancer	1.29e-05	0.00012	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ALDH2—esophageal cancer	1.29e-05	0.00012	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ADH7—esophageal cancer	1.28e-05	0.000119	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.28e-05	0.000119	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GNG7—esophageal cancer	1.28e-05	0.000119	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.26e-05	0.000117	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—TPI1—esophageal cancer	1.26e-05	0.000117	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.25e-05	0.000117	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYP19A1—esophageal cancer	1.24e-05	0.000116	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.24e-05	0.000115	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.23e-05	0.000115	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—MYC—esophageal cancer	1.22e-05	0.000114	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—GSTT1—esophageal cancer	1.22e-05	0.000114	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYP19A1—esophageal cancer	1.21e-05	0.000113	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.21e-05	0.000112	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.21e-05	0.000112	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.2e-05	0.000112	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—EGFR—esophageal cancer	1.2e-05	0.000111	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.17e-05	0.000109	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ENO1—esophageal cancer	1.17e-05	0.000109	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.16e-05	0.000108	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PSME1—esophageal cancer	1.16e-05	0.000108	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PSME2—esophageal cancer	1.16e-05	0.000108	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.15e-05	0.000107	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—ENO1—esophageal cancer	1.15e-05	0.000107	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PTGS1—esophageal cancer	1.15e-05	0.000107	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.15e-05	0.000107	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.14e-05	0.000106	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—HMOX1—esophageal cancer	1.13e-05	0.000105	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.13e-05	0.000105	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.13e-05	0.000105	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PSME2—esophageal cancer	1.13e-05	0.000105	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PSME1—esophageal cancer	1.13e-05	0.000105	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.13e-05	0.000105	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.12e-05	0.000105	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.12e-05	0.000104	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—HMOX1—esophageal cancer	1.11e-05	0.000103	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GNG7—esophageal cancer	1.1e-05	0.000102	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—ABCB1—esophageal cancer	1.09e-05	0.000101	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—TYMP—esophageal cancer	1.07e-05	0.0001	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ENO1—esophageal cancer	1.07e-05	9.96e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.07e-05	9.96e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—ABCB1—esophageal cancer	1.06e-05	9.89e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PSME2—esophageal cancer	1.06e-05	9.81e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PSME1—esophageal cancer	1.06e-05	9.81e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.05e-05	9.78e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.05e-05	9.72e-05	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—PIK3CA—esophageal cancer	1.04e-05	9.66e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.03e-05	9.55e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.02e-05	9.48e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.01e-05	9.4e-05	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TP53—esophageal cancer	1.01e-05	9.35e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP1B1—esophageal cancer	9.99e-06	9.29e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—GSTT1—esophageal cancer	9.77e-06	9.08e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP1B1—esophageal cancer	9.75e-06	9.06e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—TPI1—esophageal cancer	9.72e-06	9.04e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTO1—esophageal cancer	9.72e-06	9.04e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP2A6—esophageal cancer	9.65e-06	8.98e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.62e-06	8.94e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—HMOX1—esophageal cancer	9.6e-06	8.93e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.42e-06	8.76e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP19A1—esophageal cancer	9.39e-06	8.73e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ALDOB—esophageal cancer	9.32e-06	8.67e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.22e-06	8.57e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—ABCB1—esophageal cancer	9.21e-06	8.57e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP19A1—esophageal cancer	9.16e-06	8.52e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PTGS1—esophageal cancer	9.15e-06	8.51e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ENO1—esophageal cancer	9.15e-06	8.51e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYP1B1—esophageal cancer	9.11e-06	8.47e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PSME2—esophageal cancer	9.02e-06	8.39e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PSME1—esophageal cancer	9.02e-06	8.39e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GAPDH—esophageal cancer	8.97e-06	8.34e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CRABP1—esophageal cancer	8.89e-06	8.27e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—HMOX1—esophageal cancer	8.57e-06	7.97e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYP19A1—esophageal cancer	8.56e-06	7.96e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GNG7—esophageal cancer	8.46e-06	7.86e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.41e-06	7.82e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—HMOX1—esophageal cancer	8.36e-06	7.78e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—ABCB1—esophageal cancer	8.22e-06	7.65e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ALDH2—esophageal cancer	7.92e-06	7.37e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.87e-06	7.32e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—HMOX1—esophageal cancer	7.81e-06	7.27e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP1B1—esophageal cancer	7.78e-06	7.24e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.66e-06	7.13e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—GSTT1—esophageal cancer	7.54e-06	7.01e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—ABCB1—esophageal cancer	7.5e-06	6.97e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYP2A6—esophageal cancer	7.45e-06	6.93e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP19A1—esophageal cancer	7.32e-06	6.8e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CREBBP—esophageal cancer	7.27e-06	6.76e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CREBBP—esophageal cancer	7.11e-06	6.61e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ENO1—esophageal cancer	7.06e-06	6.57e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PTGS1—esophageal cancer	7.06e-06	6.57e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.97e-06	6.48e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PSME1—esophageal cancer	6.96e-06	6.47e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PSME2—esophageal cancer	6.96e-06	6.47e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—HMOX1—esophageal cancer	6.68e-06	6.21e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.55e-06	6.09e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—NOS3—esophageal cancer	6.51e-06	6.06e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—ABCB1—esophageal cancer	6.41e-06	5.96e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—NOS3—esophageal cancer	6.37e-06	5.92e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.22e-06	5.78e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CREBBP—esophageal cancer	6.16e-06	5.73e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYP1B1—esophageal cancer	6.01e-06	5.58e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PTGS2—esophageal cancer	5.96e-06	5.54e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PTGS2—esophageal cancer	5.82e-06	5.41e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.67e-06	5.27e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.65e-06	5.25e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—NOS3—esophageal cancer	5.51e-06	5.13e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CREBBP—esophageal cancer	5.5e-06	5.11e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CREBBP—esophageal cancer	5.36e-06	4.99e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—HMOX1—esophageal cancer	5.15e-06	4.79e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PTGS2—esophageal cancer	5.04e-06	4.69e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CREBBP—esophageal cancer	5.01e-06	4.66e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—EP300—esophageal cancer	4.95e-06	4.61e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—ABCB1—esophageal cancer	4.95e-06	4.6e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—NOS3—esophageal cancer	4.92e-06	4.58e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.84e-06	4.51e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—EP300—esophageal cancer	4.84e-06	4.5e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—NOS3—esophageal cancer	4.8e-06	4.47e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PTGS2—esophageal cancer	4.5e-06	4.19e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—NOS3—esophageal cancer	4.49e-06	4.17e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PTGS2—esophageal cancer	4.39e-06	4.09e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CREBBP—esophageal cancer	4.28e-06	3.98e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—EP300—esophageal cancer	4.19e-06	3.9e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PTGS2—esophageal cancer	4.1e-06	3.82e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NOS3—esophageal cancer	3.83e-06	3.57e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—EP300—esophageal cancer	3.74e-06	3.48e-05	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PIK3CA—esophageal cancer	3.66e-06	3.41e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—EP300—esophageal cancer	3.65e-06	3.4e-05	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PIK3CA—esophageal cancer	3.58e-06	3.33e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PTGS2—esophageal cancer	3.51e-06	3.26e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—EP300—esophageal cancer	3.41e-06	3.17e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.31e-06	3.07e-05	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PIK3CA—esophageal cancer	3.1e-06	2.89e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NOS3—esophageal cancer	2.96e-06	2.75e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—EP300—esophageal cancer	2.92e-06	2.71e-05	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PIK3CA—esophageal cancer	2.77e-06	2.58e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.71e-06	2.52e-05	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.7e-06	2.51e-05	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.52e-06	2.35e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—EP300—esophageal cancer	2.25e-06	2.09e-05	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PIK3CA—esophageal cancer	2.16e-06	2.01e-05	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.67e-06	1.55e-05	CbGpPWpGaD
